STAT3 and neoplasm: STAT3 signaling in CAFs [185] and tumor cells [185,186] may induce stromal remodeling of the TME characterized by fibrogenesis, a dysregulated organization of the ECM, and fibroblast contractility, which promote tumor cell motility, invasive activity, and resistance to chemical and immunological therapies [187].